Effects of hormonal treatment on lipids in patients with cancer

Theodosios D. Filippatos(The Royal Free Hospital), D.P. Mikhailidis(The Royal Free Hospital), Nikolaos Pavlidis(University Hospital of Ioannina), Moses Elisaf(University of Ioannina), Evangelos Liberopoulos(National and Kapodistrian University of Athens)
Cancer Treatment Reviews
November 15, 2008
10.1016/j.ctrv.2008.09.007
Cited by 62

Related Papers

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
|Metabolism|2017|251
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
|Current Vascular Pharmacology|2011|197
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2010|166
Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
|Leukemia & lymphoma/Leukemia and lymphoma|2006|160
Advanced stage clear-cell epithelial ovarian cancer: The Hellenic cooperative oncology group experience
|Gynecologic Oncology|2006|146